3 Boomerang Capital Growth Recapitalization of Enjoin, LLC

November 21, 2024

3 Boomerang Capital completed a majority growth recapitalization of Enjoin, LLC, a Clinical Documentation Integrity (CDI) and mid-revenue cycle solutions provider for hospitals and health systems. The investment will supply strategic resources and capital to expand Enjoin's tech-enabled CDI capabilities and support continued growth across healthcare provider markets.

Buyers
3 Boomerang Capital
Targets
Enjoin, LLC
Location
Tennessee, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.